Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China
- Endurance RP Limited is pleased to announce its commercial strategic partner Wanbang Biopharmaceutical Co., Ltd. has successfully completed the Phase 3 double-blind placebo-controlled study of... | April 17, 2023
Source: marketscreener.com